People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vivace Therapeutics, Inc. | — | Biotechnology | Series B | $60.5M | $94.0M | 2015 |
| Lead Therapeutics, Inc. | — | Biotechnology | Seed | $3.0M | $133.2M | 2009 |
Shuang Qiao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shuang Qiao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leonard Post | 2 | 3 |
| Tim Shannon | 1 | 9 |
| Jake Simson | 1 | 6 |
| Arthur Pappas | 1 | 3 |
| Alain Schreiber | 1 | 3 |
| Edward Hu | 1 | 2 |
| Peter Myers | 1 | 1 |
| Sheng Ding | 1 | 1 |
| Jun Wu | 1 | 1 |
| Chenguang Zhou | 1 | 1 |
| David Hanabusa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.